These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24032258)

  • 1. Evolution of the indications for genetic amniocentesis after the introduction of the prenatal screening program by the national health insurance in Poland.
    Ciach K; Swiatkowska-Freund M; Preis K
    Ginekol Pol; 2013 Jun; 84(6):418-21. PubMed ID: 24032258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indications for genetic amniocentesis investigated at the Department of Gynecology, Obstetrics, and Oncologic Gynecology, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz].
    Sadłecki P; Walentowicz-Sadłecka M; Pasińska M; Adamczak R; Grabiec M
    Ginekol Pol; 2014 Jun; 85(6):420-3. PubMed ID: 25029805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of place of residence on indications for genetic amniocentesis in the Pomeranian region of Poland before and after introduction of the Prenatal Screening Program in 2008.
    Ciach K; Swiatkowska-Freund M; Preis K
    Med Sci Monit; 2014 May; 20():720-4. PubMed ID: 24785299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the course of pregnancy and labor after genetic amniocenthesis in women after 35 years of age].
    Kowalczyk D; Wiecek J; Guzikowski W; Ośko A
    Ginekol Pol; 2011 Oct; 82(10):738-42. PubMed ID: 22379936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between indication for amniocentesis and the time of its performing.
    Preis K; Ciach K; Swiatkowska-Freund M
    Ginekol Pol; 2004 Oct; 75(10):760-4. PubMed ID: 15587906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older.
    Zoppi MA; Ibba RM; Putzolu M; Floris M; Monni G
    Obstet Gynecol; 2001 Jun; 97(6):916-20. PubMed ID: 11384696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The course of pregnancy and delivery in women after genetic amniocentesis before and after 35 years of age].
    Ciach K; Preis K; Swiatkowska-Freund M; Wydra D
    Ginekol Pol; 2008 Jan; 79(1):12-6. PubMed ID: 18510044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early or late amniocentesis--which method is safer?].
    Ciach K; Preis K; Swiatkowska-Freund M; Wydra D
    Ginekol Pol; 2007 May; 78(5):400-4. PubMed ID: 17867334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of amniocenteses performed for advanced maternal age and various other indications in Turkish women.
    Danisman N; Kahyaoglu S; Celen S; Kahyaoglu I; Candemir Z; Yesilyurt A; Cakar ES
    J Matern Fetal Neonatal Med; 2013 Feb; 26(3):242-5. PubMed ID: 23025698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic amniocentesis in the II Department of Obstetrics and Gynecology of the Medical University of Warsaw].
    Milewczyk P; Lipiński T; Hamela-Olkowska A; Jalinik K; Czajkowski K; Zaremba J
    Ginekol Pol; 2004 Aug; 75(8):603-8. PubMed ID: 15517783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method of risk assessment affects acceptance rate of amniocentesis.
    de la Vega A; Verdiales M; Leavitt G
    P R Health Sci J; 2002 Sep; 21(3):233-5. PubMed ID: 12243114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do patients decline amniocentesis? Analysis of factors influencing the decision to refuse invasive prenatal testing.
    Sadlecki P; Grabiec M; Walentowicz P; Walentowicz-Sadlecka M
    BMC Pregnancy Childbirth; 2018 May; 18(1):174. PubMed ID: 29769050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
    Nakata N; Wang Y; Bhatt S
    Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective exploratory study of fetal genetic invasive procedures at a University Hospital.
    Andrew C; Koshy T; Gopal S; Paul SFD
    J Obstet Gynaecol; 2018 Oct; 38(7):906-910. PubMed ID: 29553859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptance of amniocentesis by women in the state of Montana (USA) who are screen positive for Down's syndrome.
    Priest JH; FitzGerald JM; Haag MM; Streets K; Vanisko M; Johnson JP
    J Med Screen; 1998; 5(4):178-82. PubMed ID: 9934647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
    Sharda S; Phadke SR
    J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for Fetal Invasive Procedures at the End of an Era.
    Krapp M; Thomsen Y; Ludwig A; Enzensberger C; Kreiselmaier P
    Ultraschall Med; 2017 Jan; 38(1):78-82. PubMed ID: 25830343
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
    Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
    Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FREQUENCIES OF FETAL CHROMOSOMAL ABERRATIONS DETECTED BY AMNIOCENTESIS: OUR 15-YEARS EXPERIENCE].
    Stoyanova V; Ivanov H; Linev A; Vachev T
    Akush Ginekol (Sofiia); 2015; 54(5):13-8. PubMed ID: 26411190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.